期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 23, 期 4, 页码 2343-2350出版社
WILEY
DOI: 10.1111/jcmm.14195
关键词
coronary artery disease; heart failure; hypertension; intestinal microbiota
资金
- National Natural Science Foundation of China [81770370]
- Scientific Research Program for Young Talents of China National Nuclear Corporation [51001]
Accumulating evidence has indicated that intestinal microbiota is involved in the development of various human diseases, including cardiovascular diseases (CVOs). In the recent years, both human and animal experiments have revealed that alterations in the composition and function of intestinal flora, recognized as gut microflora dysbiosis, can accelerate the progression of CVDs. Moreover, intestinal flora metabolizes the diet ingested by the host into a series of metabolites, including trimethylamine N-oxide, short chain fatty acids, secondary bile acid and indoxyl sulfate, which affects the host physiological processes by activation of numerous signalling pathways. The aim of this review was to summarize the role of gut microbiota in the pathogenesis of CVDs, including coronary artery disease, hypertension and heart failure, which may provide valuable insights into potential therapeutic strategies for CVD that involve interfering with the composition, function and metabolites of the intestinal flora.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据